Carcinoma, Ductal clinical trials

The registry lists 20 studies for Carcinoma, Ductal across 9 countries. 3 are recruiting or about to start. 6 of them are mainly about Carcinoma, Ductal (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-13. Counting its 2 narrower conditions too, such as Carcinoma, Ductal, Breast: 162 studies, 20 open.

Get an email when these change. Save the Carcinoma, Ductal studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 9
Active, not recruiting: 3
Status unknown: 2
Terminated: 2
Recruiting: 2
Not yet recruiting: 1

Phase

Phase 2: 5
Phase 1: 4
Early Phase 1: 2
Phase 4: 1

Where

United States: 16
France: 3
Belgium: 1
Spain: 1
Canada: 1
Singapore: 1

Who runs them

Eli Lilly and Company (1) · Abramson Cancer Center at Penn Medicine (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Dana-Farber Cancer Institute (1) · Novartis Pharmaceuticals (1) · Memorial Sloan Kettering Cancer Center (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · Carisma Therapeutics Inc (1)

What is being tested here

Drugs under test in Carcinoma, Ductal studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	All
Exemestane	1	1
Tamoxifen	1	1
Talimogene laherparepvec	0	1
Spartalizumab	0	1
Canakinumab	0	1
CJM-112	0	1
Nazartinib	0	1
Indocyanine Green	0	1
Pemetrexed	0	1
Letrozole	0	1

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

May 2027Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors · University of California, Irvine
Aug 2027Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer · Dana-Farber Cancer Institute

Who these studies take

Of the 2 Carcinoma, Ductal studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
Age	Women	Men
10	0 (0%)	0 (0%)
18	2 (100%)	2 (100%)
30	2 (100%)	2 (100%)
40	2 (100%)	2 (100%)
50	2 (100%)	2 (100%)
65	2 (100%)	2 (100%)
75	2 (100%)	2 (100%)
85	2 (100%)	2 (100%)

Across all 20 studies, recruiting or not: 10% stop at 75 or younger and 0% at 65; 5% take children; 45% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 20 of 20. search them.